NASDAQ:AMEHApollo Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Apollo Medical Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $17.77 +0.60 (+3.49 %) (As of 08/10/2020 04:00 PM ET) Add Compare Share Today's Range$17.28Now: $17.77▼$18.0050-Day Range$15.53MA: $16.60▼$17.3052-Week Range$9.27Now: $17.77▼$23.26Volume112,776 shsAverage Volume70,480 shsMarket Capitalization$943.18 millionP/E Ratio30.64Dividend YieldN/ABeta0.4 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Apollo Medical. Previous Next 2.2 Community Rank Outperform VotesApollo Medical has received 121 “outperform” votes. (Add your “outperform” vote.)Underperform VotesApollo Medical has received 150 “underperform” votes. (Add your “underperform” vote.)Community SentimentApollo Medical has received 55.35% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Apollo Medical and other stocks. Vote “Outperform” if you believe AMEH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AMEH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldApollo Medical does not currently pay a dividend.Dividend GrowthApollo Medical does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Apollo Medical insiders have sold 1,909.58% more of their company's stock than they have bought. Specifically, they have bought $30,396.00 in company stock and sold $610,831.00 in company stock.Percentage Held by InsidersOnly 11.87% of the stock of Apollo Medical is held by insiders.Percentage Held by InstitutionsOnly 6.61% of the stock of Apollo Medical is held by institutions. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Apollo Medical are expected to grow by 40.91% in the coming year, from $0.66 to $0.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Apollo Medical is 30.64, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Apollo Medical is 30.64, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.78.Price to Earnings Growth RatioApollo Medical has a PEG Ratio of 5.20. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioApollo Medical has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.82 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Management consulting services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMEH Previous Symbol CUSIPN/A CIK1083446 Webwww.apollomed.net Phone626-282-0288Debt Debt-to-Equity Ratio1.16 Current Ratio2.98 Quick Ratio2.98Price-To-Earnings Trailing P/E Ratio30.64 Forward P/E Ratio26.92 P/E Growth5.2 Sales & Book Value Annual Sales$560.62 million Price / Sales1.68 Cash Flow$1.08 per share Price / Cash Flow16.44 Book Value$5.51 per share Price / Book3.23Profitability EPS (Most Recent Fiscal Year)$0.43 Net Income$14.12 million Net Margins3.24% Return on Equity11.90% Return on Assets3.15%Miscellaneous Employees475 Outstanding Shares53,077,000Market Cap$943.18 million Next Earnings Date11/5/2020 (Estimated) OptionableNot Optionable $17.77 +0.60 (+3.49 %) (As of 08/10/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive AMEH News and Ratings via Email Sign-up to receive the latest news and ratings for AMEH and its competitors with MarketBeat's FREE daily newsletter. Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions How has Apollo Medical's stock been impacted by COVID-19 (Coronavirus)? Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AMEH stock has increased by 26.3% and is now trading at $17.77. View which stocks have been most impacted by Coronavirus. When is Apollo Medical's next earnings date? Apollo Medical is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for Apollo Medical. How were Apollo Medical's earnings last quarter? Apollo Medical Holdings Inc (NASDAQ:AMEH) announced its quarterly earnings results on Wednesday, May, 27th. The company reported $0.11 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.04 by $0.07. The company earned $165.11 million during the quarter. Apollo Medical had a net margin of 3.24% and a return on equity of 11.90%. View Apollo Medical's earnings history. Has Apollo Medical been receiving favorable news coverage? News coverage about AMEH stock has been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Apollo Medical earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Apollo Medical. Are investors shorting Apollo Medical? Apollo Medical saw a drop in short interest in July. As of July 31st, there was short interest totaling 492,800 shares, a drop of 10.2% from the July 15th total of 548,900 shares. Based on an average daily volume of 80,700 shares, the short-interest ratio is presently 6.1 days. Currently, 2.7% of the company's shares are sold short. View Apollo Medical's Short Interest. Who are some of Apollo Medical's key competitors? Some companies that are related to Apollo Medical include ICF International (ICFI), Huron Consulting Group (HURN), RMR Group (RMR), The Hackett Group (HCKT), Diamond Eagle Acquisition (ATCX), Blackrock Capital Investment (BKCC), Avalon Globocare (AVCO), Information Services Group (III), ATIF (ATIF), Lightbridge (LTBR), Pharma Bio Serv (PBSV), Wilhelmina International (WHLM), TSS (TSSI), Hudson Capital (HUSN) and China Internet Nationwide Fncl Srvcs (CIFS). View all competitors. What other stocks do shareholders of Apollo Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include Paypal (PYPL), SEA (SE), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), NVIDIA (NVDA), Okta (OKTA), Alibaba Group (BABA), Mastercard (MA), Invesco QQQ Trust (QQQ) and Exxon Mobil (XOM). Who are Apollo Medical's key executives? Apollo Medical's management team includes the following people: Dr. Kenneth T. Sim M.D., Exec. ChairmanDr. Thomas S. Lam, CEO & Director (Age 70)Mr. Eric Chin, Chief Financial OfficerMr. Hing Ang, Chief Operating OfficerDr. Albert Young M.D., Co-Chief Medical Officer What is Apollo Medical's stock symbol? Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH." Who are Apollo Medical's major shareholders? Apollo Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Swiss National Bank (0.12%), Manchester Financial Inc. (0.10%), WINTON GROUP Ltd (0.06%), Virtu Financial LLC (0.02%), New York State Common Retirement Fund (0.02%) and UBS Group AG (0.01%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, Thomas S Lam and Warren Hosseinion. View institutional ownership trends for Apollo Medical. Which institutional investors are selling Apollo Medical stock? AMEH stock was sold by a variety of institutional investors in the last quarter, including Manchester Financial Inc., and UBS Group AG. View insider buying and selling activity for Apollo Medical. Which institutional investors are buying Apollo Medical stock? AMEH stock was acquired by a variety of institutional investors in the last quarter, including Swiss National Bank, Virtu Financial LLC, New York State Common Retirement Fund, and WINTON GROUP Ltd. Company insiders that have bought Apollo Medical stock in the last two years include Albert Waichow Young, Eric Chin, John Chiang, Kenneth T Sim, Mark Fawcett, Michael F Eng, Physicians Of Californi Allied, and Thomas S Lam. View insider buying and selling activity for Apollo Medical. How do I buy shares of Apollo Medical? Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Apollo Medical's stock price today? One share of AMEH stock can currently be purchased for approximately $17.77. How big of a company is Apollo Medical? Apollo Medical has a market capitalization of $943.18 million and generates $560.62 million in revenue each year. The company earns $14.12 million in net income (profit) each year or $0.43 on an earnings per share basis. Apollo Medical employs 475 workers across the globe. What is Apollo Medical's official website? The official website for Apollo Medical is www.apollomed.net. How can I contact Apollo Medical? Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at 626-282-0288 or via email at [email protected] This page was last updated on 8/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
